FDA’s proposed rule to revoke soy protein label claims for heart health ignores research supporting the claims and relies on less-than-compelling evidence, dietary supplement industry trade groups say in comments to the agency.
In its separate comment on a separate supplement market regulatory issue FDA is considering, one of the groups, the Council...





